New assets have entered clinic, whilst dozens more have been disclosed, and recent investments such as, T-Therapeutics’ $91M Series A extension to advance their bispecific towards the clinic and Anocca’s SEK 440M raise, pinpoint how funding and portfolio decisions have the power to define the […]

Biopharma investment into the formulation, delivery, and commercialization of intranasal therapies is at an all-time high, and there has never been such an opportunistic time to pursue nasal delivery. Alongside the market […]

Returning for its 8th year, LEAP HR: Life Sciences West brings together 100+ senior HR leaders from scaling and stabilizing biotech organizations to navigate volatility and drive measurable business impact. […]